Trials / Unknown
UnknownNCT00273000
The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (planned)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to study the effect of GLP-2 on mesenteric bloodflow in healthy adults by the use of ultrasound., it is the hypothesis that GLP-2 vil increase the bloodflow.
Detailed description
The investigation will include 10 testpersons. It will be a 2 fase study over 2 days. day 1: The testperson will meet fasting, and take in a standard liquid meal, after this the bloodflow in a mesenteric artery will be measured by use of ultrasonic technique. Bloodsamples will be taken regular in a total wolumne of 200 ml. day 2:The testperson will meet fasting, there wil be administered intraveneous GLP-2 in 3 increasing doses over 3 x 45 min.and one subcutaneous dose. During this the bloodflow in a mesenteric artery will be measured by use of ultrasonic technique. Bloodsamples will be taken regular in a total wolumne of 200 ml.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLP-2 |
Timeline
- Start date
- 2006-01-01
- First posted
- 2006-01-09
- Last updated
- 2006-09-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00273000. Inclusion in this directory is not an endorsement.